藥
02126
藥明巨諾－Ｂ
2.200
+0.010+0.46%Closed16:08 09/18 HKT
OPEN/PREV CLOSE2.380/2.370
TODAY RANGE2.380-2.860
VOL5.38M
MARKET CAP1.16B
52 WEEK RANGE1.400-4.980
AVG VOL (3M)1.02M
% TURNOVER1.29%
TURNOVER14.33M
P/E (TTM)-2.973
% RANGE20.25%
EPS(TTM)-0.935
P/E(FORWARD)-3.082
P/B2.224
BVPS1.250
DIVIDEND--
P/S3.486
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.16B
SHARES OUTSTANDING416.77M
NEXT EARNINGS--
FREE FLOAT416.77M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·08/28 10:31
JW (Cayman) Therapeutics (SEHK:2126) Narrows Losses As Revenue Holds Steady
Simply Wall St·03/27 19:06
JW Cayman Therapeutics SEHK 2126 Loss Of C¥267m Tests Bullish Growth Narratives
Simply Wall St·02/16 22:06
Why Investors Shouldn't Be Surprised By JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 25% Share Price Plunge
Simply Wall St·12/22/2025 23:59
Is JW (Cayman) Therapeutics (HKG:2126) A Risky Investment?
Simply Wall St·10/14/2025 23:32
Little Excitement Around JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) Revenues As Shares Take 25% Pounding
Simply Wall St·09/23/2025 22:17
Is JW (Cayman) Therapeutics (HKG:2126) Weighed On By Its Debt Load?
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.